NIH and HeroX Unveil Winners of the ARISE-HIV LAUNCH Challenge Focused on HIV Solutions

NIH and HeroX Reveal Phase 1 Winners of the ARISE-HIV LAUNCH Challenge

The National Institutes of Health (NIH), through its Office of AIDS Research (OAR), has partnered with HeroX—an innovative platform designed for crowdsourcing solutions—to highlight the recipients of the Phase 1 round of the ARISE-HIV LAUNCH Challenge. This vital initiative aims to generate actionable solutions for delivering long-lasting HIV prevention and treatment in real-world environments.

Approximately 1.2 million individuals in the United States are currently living with HIV, with about 1 in 8 of them unaware of their status. This reality underscores the urgent necessity for enhanced treatment delivery models that can significantly improve access and continuous engagement with care. The ARISE acronym stands for Advancing Research in Implementation Science to End HIV, emphasizing the focus on practical research for real-world application.

The challenge invited contributions from diverse stakeholders including researchers, public health practitioners, community organizations, healthcare professionals, advocates, and emerging scholars. Participants were encouraged to submit concept papers detailing innovative approaches centered on the delivery of long-acting HIV prevention and treatment strategies.

Submissions were rigorously evaluated based on their potential to generate practical, community-driven ideas that can improve the HIV service delivery landscape. Notably, these concepts did not require prototypes or preliminary data, thereby allowing a wide array of creative solutions aimed at improving HIV care and access.

In recognition of their innovative contributions, the winning teams—35 in total—will each receive a grant of $10,000 to develop their ideas further. These successful participants will advance to Phase 2 of the initiative, where they will be supported in crafting comprehensive implementation plans. These plans will define milestones, deliverables, outcome measures, and evaluation criteria, ensuring that the proposed solutions can be effectively executed.

Jamie Elliott, Director of Customer Success at HeroX, congratulated the winners, acknowledging the wide-ranging expertise they bring from the communities most impacted by HIV. Elliott stated, "This group exemplifies that the best ideas for delivering HIV prevention and treatment are already out there, especially from those who experience these challenges firsthand."

The selection process for the Phase 1 winners considered over 100 diverse submissions that demonstrated a significant desire within the HIV research and practice community to rethink and innovate around long-lasting prevention and treatment methods. The submissions came from a range of backgrounds including academic institutions, clinical care sites, nonprofits, and even independent solvers, spanning urban areas and rural communities alike, especially in regions experiencing higher incidences of HIV.

The innovative proposals highlighted various delivery settings, with pharmacies and digital platforms emerging as leading models for outreach, closely followed by mobile units, community organizations, hospitals, and Federally Qualified Health Centers (FQHCs). Some innovative ideas included leveraging correctional facilities and telehealth services, demonstrating a commitment to reach even the most underserved communities. Many concepts also included strategies for combining multiple service delivery settings to enhance accessibility and effectiveness.

The NIH ARISE-HIV LAUNCH Challenge is a part of a broader effort by the NIH Office of AIDS Research to tackle the HIV pandemic effectively. Through initiatives like this, the NIH aims to amplify research efforts and improve health outcomes for individuals affected by HIV.

For more details about the winning teams and to explore their innovative approaches, you can visit the official HeroX page dedicated to the ARISE-HIV LAUNCH Challenge.

Conclusion

The ARISE-HIV LAUNCH Challenge and its outcomes offer a promising glimpse into the future of HIV treatment and prevention. By fostering creative ideas and supporting diverse partners, the NIH and HeroX are paving the way toward a world where everyone has access to the care they need. Through this collaborative spirit and innovative thinking, there is hope for a significant reduction in the impact of HIV across the nation.

To learn more about the challenge and its implications, please visit NIH ARISE-HIV LAUNCH Challenge.